FOXO3 and familial pancreatic carcinoma: In the context of tumorigenesis, O-GlcNAcylation at FOXO3 Ser284 abrogates its tumor suppressor activity by activating the MDM2-p53-p21 signaling, leading to accelerated pancreatic cancer cell growth (Shin et al. 2018).